Richard Scheffler acted as a panelist at a webinar hosted by the Partnership to Empower Physician-Led Care, an advocacy group promoting value-based care as a path to sustainability for independent physicians and practices. The webinar discussed provider consolidation’s impact on health outcomes and how best to ensure provider competitive behavior instead. Specifically, Dr. Scheffler touched on issues related to increasing private equity investments and vertical integration in healthcare, effects on prices, and next steps at the legislative level.
The title is “Addressing Consolidation in Health Care Markets: The Impact of Provider Consolidation on Cost and Quality.” Take a look here — 10:10 to 27:20.
Blue Cross and Blue Shield of North Carolina has partnered with investment firm Deerfield Management Company in a joint venture aimed at helping independent physicians grow and strengthen their practices. The company will offer management infrastructure, technology support and marketplace information. Modern Healthcare sought comments from Dr. Richard Scheffler on the effects of this joint venture on independent physician practices, with Scheffler noting that this could help these physicians “ease the difficulty of managing their own small practice in today’s healthcare environment.”
Read the full article and all of Dr. Scheffler’s insights here.
Modern Healthcare interviewed Richard Scheffler for an article discussing the growing trend of private equity investment in the healthcare sector. They also cite his recent report on the topic. The interview took place after the noteworthy buyout of medical supply company Medline by a trio of private equity firms—Blackstone Group, Carlyle and Hellman & Friedman. As Dr. Scheffler puts it, this may be “the start of an explosion of private equity deals in healthcare.”
Read the full article here.
The Petris Center and American Antitrust Institute (AAI)’s joint report on rising private equity investment in the healthcare industry was cited during the May 19 hearing of the U.S. Senate Committee on the Judiciary’s Subcommittee on Competition Policy, Antitrust, and Consumer Rights as part of the discussion about hospital consolidation and competition. The Petris Center’s Richard Scheffler and AAI’s Laura Alexander were recognized by name as the authors of this report.
Senator Blumenthal (D-CT) expressed concern over the impact of private equity investment on hospital consolidation and quality of patient care. He asked witness Professor Martin S. Gaynor of Carnegie Mellon University for his assessment of the role of hospital debt burden in necessitating hospital closures or mergers. Professor Gaynor then cited Richard Scheffler and Laura Alexander’s recent private equity report, noting that there is significant concern about private equity activity leading to consolidation and potentially diminishing quality of care due to misaligned incentives between private equity investors and patients and physicians.
Hear Senator Blumenthal and Professor Gaynor’s discussion of hospital consolidation and the private equity report during the May 19 hearing, beginning at about 1:25.
Jamie Godwin, Daniel Arnold, Brent Fulton, and Richard Scheffler collaborated and studied the relationship between hospital ownership of physician organizations and prices in “The Association between Hospital-Physician Vertical Integration and Outpatient Physician Prices Paid by Commercial Insurers: New Evidence“. The widespread acquisition of physician practices by hospitals and health systems—a practice known as vertical integration—has been the most significant shift in healthcare provider market structure over the past decade. Market-level hospital-physician vertical integration was positively associated with physician prices for select specialties but was not associated with changes in the use of facility-fee billing. The authors call for more research to be done on quality effects of hospital-physician vertical integration.
The Petris Center has continued to guide public policy and analyze healthcare markets despite not meeting in-person. To see our accomplishments, we have released our 2020 Newsletter!
Daniel Arnold and Christopher Whaley’s paper, “Who Pays for Health Care Costs? The Effects of Health Care Prices on Wages“, was presented at the Thirteenth Annual FTC Microeconomics Conference. It explores the relationship between rising health care costs and slower wage growth for employer-sponsored insurance.
Using hospital market structure and price assessed for Metropolitan Statistical Areas, they find hospital mergers lead to a $521 increase in hospital prices, a $579 increase in mean hospital spending, and a $638 reduction in wages. The results support that hospital mergers affect consumers through lower wages. Both the direct cost of medical care and the indirect cost to wages and should be considered in health care reforms.
Hear Chris Whaley present the paper on Day 1 (PM) of the conference.
Richard Scheffler speaks in an episode of Tradeoffs, a podcast that focuses on research and policy in the health industry. Having conducted a major study regarding costs of healthcare services in California, Richard would come to encounter the importance of this data in addressing anti-competitive practices. The episode explores the role he played in California Attorney General Xavier Becerra’s significant case and settlement with Sutter Health.
Have a listen!
Richard Scheffler hosts a presentation on the future of health policy under The Biden Administration. Join him on Friday (1/29) at 1:30 PST to learn more about proposed and potential direction of healthcare in the U.S.
Listen to his event here. He touches upon public option, healthcare payment systems, the direction of telehealth, the impact of COVID-19, and prescription drug pricing.
Richard Scheffler and Surina Khurana analyze California Attorney General Xavier Becerra’s experience in health policy as The Senate confirms his nomination for Secretary of Health and Human Services. His record includes defense for the Affordable Care Act, litigation for Sutter Health’s antitrust practices, and persecution for pay-for-delay practices. For his new role in the government’s insurance programs and pays for prescription drugs, he is qualified and well prepared.